Barely Significant
← all excerpts

Pharmacokinetic-pharmacodynamic target attainment analyses as support for meropenem dosing regimens in critically ill adult and elderly patients with <i>Pseudomonas aeruginosa</i> infections.

Front Pharmacol · 2025 · PMC12510855 · PMID 41079739

2
hedged sentences
closest p
boldest claim

The sentences

a notable trendno p-value reported
A notable trend of decreasing CrCL was observed as the age of patients increased, which consequently led to a reduction in the CL of meropenem.

also in 2,105 other papers

a clear trendno p-value reported
As illustrated in Figure 2 , the age-normalized Vd increased with advancing age, indicating a clear trend across different age groups. 3.4 Model validation The robustness and stability of the final pharmacokinetic model were evaluated using both bootstrapping ( Table 2 ) and prediction-corrected visual predictive checks ( Figure 3 ).

also in 12,136 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.